19-10986906-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2
The NM_003072.5(SMARCA4):āc.762T>Cā(p.Gly254Gly) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000336 in 1,609,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003072.5 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 5/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 5/35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 5/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 5/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 5/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 6/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 5/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 5/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.762T>C | p.Gly254Gly | splice_region_variant, synonymous_variant | 6/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.174T>C | p.Gly58Gly | splice_region_variant, synonymous_variant | 2/32 | ENSP00000496004.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250354Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135468
GnomAD4 exome AF: 0.0000336 AC: 49AN: 1457340Hom.: 0 Cov.: 31 AF XY: 0.0000331 AC XY: 24AN XY: 725254
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74324
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 16 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 22, 2017 | Not observed at a significant frequency in large population cohorts (Lek 2016); Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown - |
Rhabdoid tumor predisposition syndrome 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at